Does TOFACITINIB Cause Colon cancer? 159 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Colon cancer have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
159
Reports of Colon cancer with TOFACITINIB
0.1%
of all TOFACITINIB reports
18
Deaths
50
Hospitalizations
How Dangerous Is Colon cancer From TOFACITINIB?
Of the 159 reports, 18 (11.3%) resulted in death, 50 (31.4%) required hospitalization, and 26 (16.4%) were considered life-threatening.
Is Colon cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Colon cancer?
RANITIDINE (1,938)
ADALIMUMAB (452)
REGORAFENIB (278)
FRUQUINTINIB (277)
ETANERCEPT (268)
LENALIDOMIDE (258)
APIXABAN (241)
INFLIXIMAB (241)
PANITUMUMAB (235)
METHOTREXATE (207)
Which TOFACITINIB Alternatives Have Lower Colon cancer Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN